- Home
- LGND vs NVG Comparison
LGND vs NVG Comparison
Compare LGND & NVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- NVG
- Stock Information
- Founded
- LGND 1987
- NVG 1999
- Country
- LGND United States
- NVG United States
- Employees
- LGND 68
- NVG N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- NVG Investment Managers
- Sector
- LGND Health Care
- NVG Finance
- Exchange
- LGND Nasdaq
- NVG Nasdaq
- Market Cap
- LGND 3.2B
- NVG 2.7B
- IPO Year
- LGND 1992
- NVG N/A
- Fundamental
- Price
- LGND $205.69
- NVG $12.65
- Analyst Decision
- LGND Strong Buy
- NVG
- Analyst Count
- LGND 8
- NVG 0
- Target Price
- LGND $144.71
- NVG N/A
- AVG Volume (30 Days)
- LGND 139.7K
- NVG 568.8K
- Earning Date
- LGND 08-05-2025
- NVG 01-01-0001
- Dividend Yield
- LGND N/A
- NVG 4.65%
- EPS Growth
- LGND N/A
- NVG N/A
- EPS
- LGND N/A
- NVG N/A
- Revenue
- LGND $181,488,000.00
- NVG N/A
- Revenue This Year
- LGND $18.41
- NVG N/A
- Revenue Next Year
- LGND $18.87
- NVG N/A
- P/E Ratio
- LGND N/A
- NVG N/A
- Revenue Growth
- LGND 53.40
- NVG N/A
- 52 Week Low
- LGND $81.74
- NVG $9.68
- 52 Week High
- LGND $129.90
- NVG $12.21
- Technical
- Relative Strength Index (RSI)
- LGND 59.63
- NVG 60.40
- Support Level
- LGND $198.82
- NVG $12.46
- Resistance Level
- LGND $209.10
- NVG $12.66
- Average True Range (ATR)
- LGND 7.14
- NVG 0.08
- MACD
- LGND -0.67
- NVG -0.00
- Stochastic Oscillator
- LGND 53.60
- NVG 72.73
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About NVG Nuveen AMT-Free Municipal Credit Income Fund
Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax and federal alternative minimum tax applicable to individuals and enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the investment adviser believes are underrated or undervalued or represent undervalued municipal market sectors.